BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 571.49B
Enterprise Value 3N/A
Trailing P/E 22.19
Forward P/E 114.57
PEG Ratio (5 yr expected) 12.36
Price/Sales (ttm)6.10
Price/Book (mrq)6.17
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 28.10%
Operating Margin (ttm)45.19%
Management Effectiveness
Return on Assets (ttm)15.30%
Return on Equity (ttm)28.62%
Income Statement
Revenue (ttm)11.72B
Revenue Per Share (ttm)54.31
Quarterly Revenue Growth (yoy)6.40%
Gross Profit (ttm)9.97B
Net Income Avi to Common (ttm)3.29B
Diluted EPS (ttm)15.24
Quarterly Earnings Growth (yoy)-17.80%
Balance Sheet
Total Cash (mrq)2.89B
Total Cash Per Share (mrq)13.68
Total Debt (mrq)6.51B
Total Debt/Equity (mrq)56.28
Current Ratio (mrq)2.10
Book Value Per Share (mrq)54.79
Cash Flow Statement
Operating Cash Flow (ttm)3.91B
Levered Free Cash Flow (ttm)2.34B

Trading Information

Stock Price History
Beta 0.47
52-Week Change 317.76%
S&P500 52-Week Change 319.09%
52 Week High 3348.84
52 Week Low 3244.28
50-Day Moving Average 3324.75
200-Day Moving Average 3285.90
Share Statistics
Avg Vol (3 month) 31.29M
Avg Vol (10 day) 31.39M
Shares Outstanding 5211.43M
Float 211.12M
% Held by Insiders 10.37%
% Held by Institutions 190.88%
Shares Short 33.09M
Short Ratio 32.28
Short % of Float 31.45%
Shares Short (prior month) 33.2M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/1
Last Split Date 3Jan 18, 2001